Impact of Covid-19 in Bangladesh Stock Market
Asian Finance & Banking Review · 26.11.2020 · 4 (2) · 22-23
DOI: 10.46281/asfbr.v4i2.896 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Finance & Banking Review, online erschienen am 26.11.2020. Verfasst von Sunjida Haque und 1 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The world's big economies are roiled and going under a devastating threat amid the impact of the COVID-19 pandemic. No country will be safe as this virus will eventually outbreak everywhere, regardless of how countries prepare to avoid it. The economic ramification as well as the stock market crisis will be uncertain due to the extended suspension of economic activities in almost every country. No wonder, the clattered stock markets of Bangladesh which have already got the adjective of “the worst stock market in the world” because of inefficient and irrational fluctuations in previous years will experience a colossal crisis due to the pandemic. The article provides an investigation on comparable analysis of the impact on stock markets of Bangladesh, Dhaka stock exchange, and Chittagong stock exchange, before and after the pandemic situation with current market data. We also examine the potential consequence of policy interventions to the market and the investors during a pandemic.
Zitieren
APA
Haque, S., & Chowdhury, T. A. (2020). Impact of Covid-19 in Bangladesh Stock Market. Asian Finance & Banking Review, 4(2), 22-23. https://doi.org/10.46281/asfbr.v4i2.896
Vancouver
Haque S, Chowdhury TA. Impact of Covid-19 in Bangladesh Stock Market. Asian Finance & Banking Review. 2020;4(2):22-23. doi:10.46281/asfbr.v4i2.896
BibTeX
@article{Haque2020,
author = {Haque, Sunjida and Chowdhury, Tanbir Ahmed},
title = {Impact of Covid-19 in Bangladesh Stock Market},
journal = {Asian Finance & Banking Review},
year = {2020},
volume = {4},
number = {2},
pages = {22--23},
doi = {10.46281/asfbr.v4i2.896}
}
EUVIMED